$3.16 Billion is the total value of BRIDGER MANAGEMENT, LLC's 44 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 42.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $74,784,000 | +14.3% | 623,880 | -0.5% | 2.36% | -45.9% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $57,309,000 | -14.6% | 469,745 | -17.2% | 1.81% | -59.6% |
| AGO | Sell | ASSURED GUARANTY LTD | $56,377,000 | -19.0% | 2,350,000 | -10.9% | 1.78% | -61.7% |
| SGMS | Sell | SCIENTIFIC GAMES CORPcl a | $56,150,000 | +29.3% | 3,613,242 | -12.9% | 1.78% | -38.8% |
| KAR | Sell | KAR AUCTION SVCS INC | $55,188,000 | -27.7% | 1,475,611 | -26.7% | 1.74% | -65.8% |
| ZTS | Sell | ZOETIS INCcl a | $54,285,000 | -30.8% | 1,125,778 | -33.6% | 1.72% | -67.3% |
| MNKKQ | Sell | MALLINCKRODT PUB LTD CO | $47,080,000 | -18.4% | 399,932 | -12.2% | 1.49% | -61.4% |
| PFSI | Sell | PENNYMAC FINL SVCS INCcl a | $33,105,000 | -3.7% | 1,826,960 | -9.8% | 1.05% | -54.4% |
| HUM | Sell | HUMANA INC | $32,290,000 | -39.8% | 168,809 | -44.0% | 1.02% | -71.5% |
| CNC | Sell | CENTENE CORP DEL | $29,917,000 | -19.9% | 372,098 | -29.6% | 0.95% | -62.1% |
| LLY | Sell | LILLY ELI & CO | $29,187,000 | +9.5% | 349,591 | -4.7% | 0.92% | -48.2% |
| TGTX | Sell | TG THERAPEUTICS INC | $25,508,000 | -19.7% | 1,537,529 | -25.1% | 0.81% | -62.0% |
| CWST | Exit | CASELLA WASTE SYS INCcl a | $0 | – | -544,220 | -100.0% | -0.20% | – |
| T107PS | Exit | WRIGHT MED GROUP INC | $0 | – | -533,638 | -100.0% | -0.92% | – |
| CMRX | Exit | CHIMERIX INC | $0 | – | -473,256 | -100.0% | -1.19% | – |
| ARWR | Exit | ARROWHEAD RESH CORP | $0 | – | -2,976,183 | -100.0% | -1.35% | – |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDadr | $0 | – | -406,756 | -100.0% | -1.69% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -527,088 | -100.0% | -1.74% | – |
| ARAY | Exit | ACCURAY INC | $0 | – | -3,903,090 | -100.0% | -2.43% | – |
| B108PS | Exit | ACTAVIS PLC | $0 | – | -234,562 | -100.0% | -4.67% | – |
| MS | Exit | MORGAN STANLEY | $0 | – | -2,000,000 | -100.0% | -4.77% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERISIGN INC | 40 | Q1 2023 | 5.2% |
| TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
| MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
| ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
| POST HLDGS INC | 33 | Q4 2022 | 6.1% |
| TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
| ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
| GODADDY INC | 28 | Q3 2023 | 8.9% |
| CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
| Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
| Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
| TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
| CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
| SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
| Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
| ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
| PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.